Lista de obras - Pilar Garrido - Dominio Público Uruguay

A new multidisciplinary Spanish Working Group on Cancer Biomarkers: presentation and aims

artículo científico publicado en 2012

Abemaciclib in Combination with Single-Agent Options in Patients with Stage IV Non-Small Cell Lung Cancer: A Phase Ib Study

scientific article published on 06 August 2018

Accurate identification of ALK positive lung carcinoma patients: novel FDA-cleared automated fluorescence in situ hybridization scanning system and ultrasensitive immunohistochemistry

artículo científico publicado en 2014

Afatinib-induced hypertrichosis of the eyelashes and eyebrows.

artículo científico publicado en 2016

Antiemetic regimens in outpatients receiving cisplatin and non-cisplatin chemotherapy. A randomized trial comparing high-dose metoclopramide plus methylprednisolone with and without lorazepam

artículo científico publicado en 1991

Biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

artículo científico publicado en 2014

Bone marrow examination in small cell lung cancer--when is it indicated?

artículo científico publicado en 1991

Consensus of the Spanish Society of Medical Oncology (SEOM) and Spanish Society of Pathology (SEAP) for HER2 testing in gastric carcinoma.

artículo científico publicado en 2011

Do new cancer drugs offer good value for money? The perspectives of oncologists, health care policy makers, patients, and the general population.

artículo científico publicado en 2015

Efficacy of oral tegafur modulation by uracil and leucovorin in advanced colorectal cancer. A phase II study

scientific article published on 01 December 1995

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial

artículo científico publicado en 2012

Evaluation of functional single nucleotide polymorphisms of different genes coding for the immunoregulatory molecules in patients with monoclonal large granular lymphocyte lymphocytosis

article

Executive summary of the SEPAR recommendations for the diagnosis and treatment of non-small cell lung cancer.

artículo científico publicado en 2016

Expanded cells in monoclonal TCR-alphabeta+/CD4+/NKa+/CD8-/+dim T-LGL lymphocytosis recognize hCMV antigens.

artículo científico publicado en 2008

FLEP (5-fluorouracil, leucovorin, etoposide, cisplatin) in advanced gastric cancer

scientific article published on 01 January 1994

Final results from a Phase II study of pemetrexed and cisplatin with concurrent thoracic radiation after Pem-Cis induction in patients with unresectable locally advanced non-squamous non-small cell lung cancer (NSCLC).

artículo científico publicado en 2015

Gemcitabine and carboplatin in advanced transitional cell carcinoma of the urinary tract: an alternative therapy

artículo científico publicado en 2003

Gender gap: surveying the world for tomorrow

artículo científico publicado en 2020

Guidelines for biomarker testing in advanced non-small-cell lung cancer. A national consensus of the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP).

artículo científico publicado en 2012

Ifosfamide and vinorelbine in advanced platinum-resistant ovarian cancer: excessive toxicity with a potentially active regimen.

artículo científico publicado en 2002

Long-term survival in a smoking caucasian male patient treated with gefitinib for spinal cord compression secondary to lung cancer

artículo científico publicado en 2011

Long-term survival in advanced non-squamous NSCLC patients treated with first-line bevacizumab-based therapy

artículo científico publicado en 2016

Lung cancer in women: an overview with special focus on Spanish women

artículo científico publicado en 2013

Management of lung cancer-associated anaemia: the Spanish Lung Cancer Anaemia Survey (SLCAS).

artículo científico publicado en 2011

Multidisciplinary approach in stage III non-small-cell lung cancer: standard of care and open questions.

artículo científico publicado en 2011

New molecular targeted therapies integrated with radiation therapy in lung cancer

artículo científico publicado en 2010

Patient involvement in clinical research: why, when, and how

artículo científico publicado en 2016

Phase 1 Study of the Efficacy and Safety of Ramucirumab in Combination with Osimertinib in Advanced T790M-Positive EGFR-Mutant Non-Small Cell Lung Cancer

artículo científico publicado en 2020

Phase III trial comparing vinflunine with docetaxel in second-line advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy

artículo científico publicado en 2010

Pilot study on workload estimate in breast cancer, lung cancer and colorectal cancer in a Medical Oncology Service at Valme hospital.

artículo científico publicado en 2012

SEOM clinical guidelines for the treatment of non-small cell lung cancer (NSCLC) 2013.

artículo científico publicado en 2013

SEOM clinical guidelines for the treatment of non-small-cell lung cancer: an updated edition.

artículo científico publicado en 2010

SEOM guidelines 2014: improving quality to increase its usefulness.

artículo científico publicado en 2014

SEOM guidelines for the management of non-small-cell lung cancer (NSCLC)

artículo científico publicado en 2009

Safety and efficacy of first-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer (SAiL, MO19390): a phase 4 study.

artículo científico publicado en 2010

Sequential dose-dense paclitaxel followed by topotecan in untreated extensive-stage small-cell lung cancer: a Spanish Lung Cancer Group phase II study ⬇️

artículo científico publicado el 1 de octubre de 2003

State of the art of radiotherapy.

artículo científico

Therapeutic Potential of Denosumab in Patients With Lung Cancer: Beyond Prevention of Skeletal Complications

artículo científico publicado en 2015

Trastuzumab Emtansine (T-DM1) in Patients with Previously Treated HER2-Overexpressing Metastatic Non-Small Cell Lung Cancer: Efficacy, Safety, and Biomarkers

artículo científico publicado en 2018

Treatment of metastatic malignant melanoma with cisplatin plus tamoxifen

scientific article published on 01 January 1996

Treatment options beyond immunotherapy in patients with wild-type lung adenocarcinoma: a Delphi consensus

artículo científico publicado en 2019

Tumor-associated macrophages: "Good cop-bad cop"

scientific article published on 12 February 2019

Updated guidelines for predictive biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

artículo científico publicado en 2019

[Erlotinib (Tarceva) induced severe exanthema]

scientific article published on 01 September 2007

[Gefitinib-induced perforating dermatosis]

scientific article published on 01 April 2006

[Secondary hypopituitarism due to hypothalamic metastasis from small cell lung cancer].

artículo científico publicado en 2009

Lista de obras de Pilar Garrido

A new multidisciplinary Spanish Working Group on Cancer Biomarkers: presentation and aims

Abemaciclib in Combination with Single-Agent Options in Patients with Stage IV Non-Small Cell Lung Cancer: A Phase Ib Study

Accurate identification of ALK positive lung carcinoma patients: novel FDA-cleared automated fluorescence in situ hybridization scanning system and ultrasensitive immunohistochemistry

Afatinib-induced hypertrichosis of the eyelashes and eyebrows.

Antiemetic regimens in outpatients receiving cisplatin and non-cisplatin chemotherapy. A randomized trial comparing high-dose metoclopramide plus methylprednisolone with and without lorazepam

Biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

Bone marrow examination in small cell lung cancer--when is it indicated?

Consensus of the Spanish Society of Medical Oncology (SEOM) and Spanish Society of Pathology (SEAP) for HER2 testing in gastric carcinoma.

Do new cancer drugs offer good value for money? The perspectives of oncologists, health care policy makers, patients, and the general population.

Efficacy of oral tegafur modulation by uracil and leucovorin in advanced colorectal cancer. A phase II study

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial

Evaluation of functional single nucleotide polymorphisms of different genes coding for the immunoregulatory molecules in patients with monoclonal large granular lymphocyte lymphocytosis

Executive summary of the SEPAR recommendations for the diagnosis and treatment of non-small cell lung cancer.

Expanded cells in monoclonal TCR-alphabeta+/CD4+/NKa+/CD8-/+dim T-LGL lymphocytosis recognize hCMV antigens.

FLEP (5-fluorouracil, leucovorin, etoposide, cisplatin) in advanced gastric cancer

Final results from a Phase II study of pemetrexed and cisplatin with concurrent thoracic radiation after Pem-Cis induction in patients with unresectable locally advanced non-squamous non-small cell lung cancer (NSCLC).

Gemcitabine and carboplatin in advanced transitional cell carcinoma of the urinary tract: an alternative therapy

Gender gap: surveying the world for tomorrow

Guidelines for biomarker testing in advanced non-small-cell lung cancer. A national consensus of the Spanish Society of Medical Oncology (SEOM) and the Spanish Society of Pathology (SEAP).

Ifosfamide and vinorelbine in advanced platinum-resistant ovarian cancer: excessive toxicity with a potentially active regimen.

Long-term survival in a smoking caucasian male patient treated with gefitinib for spinal cord compression secondary to lung cancer

Long-term survival in advanced non-squamous NSCLC patients treated with first-line bevacizumab-based therapy

Lung cancer in women: an overview with special focus on Spanish women

Management of lung cancer-associated anaemia: the Spanish Lung Cancer Anaemia Survey (SLCAS).

Multidisciplinary approach in stage III non-small-cell lung cancer: standard of care and open questions.

New molecular targeted therapies integrated with radiation therapy in lung cancer

Patient involvement in clinical research: why, when, and how

Phase 1 Study of the Efficacy and Safety of Ramucirumab in Combination with Osimertinib in Advanced T790M-Positive EGFR-Mutant Non-Small Cell Lung Cancer

Phase III trial comparing vinflunine with docetaxel in second-line advanced non-small-cell lung cancer previously treated with platinum-containing chemotherapy

Pilot study on workload estimate in breast cancer, lung cancer and colorectal cancer in a Medical Oncology Service at Valme hospital.

SEOM clinical guidelines for the treatment of non-small cell lung cancer (NSCLC) 2013.

SEOM clinical guidelines for the treatment of non-small-cell lung cancer: an updated edition.

SEOM guidelines 2014: improving quality to increase its usefulness.

SEOM guidelines for the management of non-small-cell lung cancer (NSCLC)

Safety and efficacy of first-line bevacizumab-based therapy in advanced non-squamous non-small-cell lung cancer (SAiL, MO19390): a phase 4 study.

Sequential dose-dense paclitaxel followed by topotecan in untreated extensive-stage small-cell lung cancer: a Spanish Lung Cancer Group phase II study ⬇️

State of the art of radiotherapy.

Therapeutic Potential of Denosumab in Patients With Lung Cancer: Beyond Prevention of Skeletal Complications

Trastuzumab Emtansine (T-DM1) in Patients with Previously Treated HER2-Overexpressing Metastatic Non-Small Cell Lung Cancer: Efficacy, Safety, and Biomarkers

Treatment of metastatic malignant melanoma with cisplatin plus tamoxifen

Treatment options beyond immunotherapy in patients with wild-type lung adenocarcinoma: a Delphi consensus

Tumor-associated macrophages: "Good cop-bad cop"

Updated guidelines for predictive biomarker testing in advanced non-small-cell lung cancer: a National Consensus of the Spanish Society of Pathology and the Spanish Society of Medical Oncology

[Erlotinib (Tarceva) induced severe exanthema]

[Gefitinib-induced perforating dermatosis]

[Secondary hypopituitarism due to hypothalamic metastasis from small cell lung cancer].